Cargando…

Development of a Novel Prognostic Model of Glioblastoma Based on m6A-Associated Immune Genes and Identification of a New Biomarker

BACKGROUND: Accumulating evidence shows that m6A regulates oncogene and tumor suppressor gene expression, thus playing a dual role in cancer. Likewise, there is a close relationship between the immune system and tumor development and progression. However, for glioblastoma, m6A-associated immunologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Na, Sun, Xizi, Ma, Shengling, Li, Xiaoyu, Zhu, Wenjun, Fu, Min, Yang, Feng, Chen, Ziqi, Li, Qianxia, Zhang, Yuanyuan, Peng, Xiaohong, Hu, Guangyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348864/ https://www.ncbi.nlm.nih.gov/pubmed/35936722 http://dx.doi.org/10.3389/fonc.2022.868415

Ejemplares similares

Development of Tumor Mutation Burden-Related Prognostic Model and Novel Biomarker Identification in Stomach Adenocarcinoma
por: Fu, Min, et al.
Publicado: (2022)

Development and validation of an inflammatory response-related prognostic model and immune infiltration analysis in glioblastoma
por: Zhu, Wenjun, et al.
Publicado: (2023)

Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach Adenocarcinoma
por: Luo, Na, et al.
Publicado: (2022)

Hypoxia Constructing the Prognostic Model of Colorectal Adenocarcinoma and Related to the Immune Microenvironment
por: Zhang, Yuanyuan, et al.
Publicado: (2021)

LASSO-based screening for potential prognostic biomarkers associated with glioblastoma
por: Tian, Yin, et al.
Publicado: (2023)

β3GNT9 as a prognostic biomarker in glioblastoma and its association with glioblastoma immune infiltration, migration and invasion
por: Luo, YingHao, et al.
Publicado: (2023)

Comprehensive Analysis of Prognostic Markers for Acute Myeloid Leukemia Based on Four Metabolic Genes
por: Zhang, Yuanyuan, et al.
Publicado: (2020)

Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma
por: Zhang, Lu-yang, et al.
Publicado: (2019)

RPP25 as a Prognostic-Related Biomarker That Correlates With Tumor Metabolism in Glioblastoma
por: Xiao, Dongdong, et al.
Publicado: (2022)

Prognostic value of prognostic nutritional index score and controlling nutritional status score in patients with glioblastoma: A comprehensive meta-analysis
por: Peng, Jie, et al.
Publicado: (2023)

A Novel RNA Binding Protein-Related Prognostic Signature for Hepatocellular Carcinoma
por: Huang, Yongbiao, et al.
Publicado: (2020)

The AlkB Family: Potential Prognostic Biomarkers and Therapeutic Targets in Glioblastoma
por: Feng, Songshan, et al.
Publicado: (2022)

Construction of m6A-Related lncRNA Prognostic Signature Model and Immunomodulatory Effect in Glioblastoma Multiforme
por: Xie, Pan, et al.
Publicado: (2022)

Malignant Evaluation and Clinical Prognostic Values of m6A RNA Methylation Regulators in Glioblastoma
por: Du, Jianyang, et al.
Publicado: (2020)

Preoperative Naples prognostic score is a reliable prognostic indicator for newly diagnosed glioblastoma patients
por: Li, Junhong, et al.
Publicado: (2022)

OSgc: A Web Portal to Assess the Performance of Prognostic Biomarkers in Gastric Cancer
por: Xie, Longxiang, et al.
Publicado: (2022)

Therapeutic Prospects of mRNA-Based Gene Therapy for Glioblastoma
por: Tang, Xiangjun, et al.
Publicado: (2019)

Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
por: Yang, Bo, et al.
Publicado: (2020)

Role of Radiation Therapy Differs Between Stages in Primary Bone Large B-Cell Lymphoma in Rituximab Era: A Population-Based Analysis
por: Ma, Shengling, et al.
Publicado: (2020)

Identification of a Specific Gene Module for Predicting Prognosis in Glioblastoma Patients
por: Tang, Xiangjun, et al.
Publicado: (2019)

ITGA3 Is Associated With Immune Cell Infiltration and Serves as a Favorable Prognostic Biomarker for Breast Cancer
por: Li, Yue, et al.
Publicado: (2021)

Multiparametric MRI and [(18)F]Fluorodeoxyglucose Positron Emission Tomography Imaging Is a Potential Prognostic Imaging Biomarker in Recurrent Glioblastoma
por: Hassanzadeh, Comron, et al.
Publicado: (2017)

SETMAR Shorter Isoform: A New Prognostic Factor in Glioblastoma
por: Lié, Oriane, et al.
Publicado: (2022)

Identification of a 3-Gene Model as Prognostic Biomarker in Patients With Gastric Cancer
por: Xue, Siming, et al.
Publicado: (2022)

A Hematological-Related Prognostic Scoring System for Patients With Newly Diagnosed Glioblastoma
por: Zhao, Chao, et al.
Publicado: (2020)

M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme
por: Wang, Li-chong, et al.
Publicado: (2020)

Identification of a prognostic signature and ENTR1 as a prognostic biomarker for colorectal mucinous adenocarcinoma
por: Huang, An, et al.
Publicado: (2023)

GFAPδ: A Promising Biomarker and Therapeutic Target in Glioblastoma
por: Radu, Roxana, et al.
Publicado: (2022)

Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response
por: Tian, Xi, et al.
Publicado: (2022)

NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma
por: Ren, Wenjun, et al.
Publicado: (2022)

HAUS5 Is A Potential Prognostic Biomarker With Functional Significance in Breast Cancer
por: Huang, Zhijian, et al.
Publicado: (2022)

LCTL Is a Prognostic Biomarker and Correlates With Stromal and Immune Infiltration in Gliomas
por: Su, Jun, et al.
Publicado: (2019)

Identification of Potential Biomarkers of Platelet RNA in Glioblastoma by Bioinformatics Analysis
por: Chen, Xianjun, et al.
Publicado: (2022)

MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma
por: Yang, Shu, et al.
Publicado: (2022)

Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels
por: Rubino, Franco, et al.
Publicado: (2022)

NCAPG as a Novel Prognostic Biomarker in Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022)

WDR5 is a prognostic biomarker of brain metastasis from non-small cell lung cancer
por: Li, Zheng, et al.
Publicado: (2022)

The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2019)

Albumin-To-Alkaline Phosphatase Ratio as a Novel and Promising Prognostic Biomarker in Patients Undergoing Esophagectomy for Carcinoma: A Propensity Score Matching Study
por: Zhu, Xianying, et al.
Publicado: (2021)

Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme
por: Liu, Erheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9mmdnumukjb0uk997ql9ku3fj9